Top Markets
#1 Islamic Coin Islamic Coin +152.25%
#2 Bitway Bitway +40.84%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +38.17%
#4 Starpower Starpower +29.00%
#5 Pleasing Gold Pleasing Gold +28.64%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.29%
#7 Pons Pons +22.64%
#8 aelf aelf +18.42%
#9 Decred Decred +14.29%
#10 Venom Venom +14.02%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Aelis Farma S.A. Aelis Farma S.A.

Aelis Farma S.A.

AELIS
Rank in Stocks #30386
Aelis Farma S.A., a French biotechnology company founded in 2013 and... Aelis Farma S.A., a French biotechnology company founded in 2013 and headquartered in Bordeaux, is dedicated to the discovery and development of treatments for brain-related illnesses. The firm's research pipeline primarily focuses on signaling-specific inhibitors that target CB1 receptors. Its leading investigational drug, AEF0117, is currently advancing through Phase 2b clinical trials, designed to alleviate the harmful impacts of excessive cannabis consumption. Furthermore, AEF0217, another key drug candidate, has successfully completed Phase 1 clinical trials, with the goal of addressing cognitive impairments linked to Down syndrome and other similar conditions.
Share Price
$1.25
Last synced: 2026-08-18
Market Cap
$17.05M
Change (1 day)
-1.50%
Change (1 year)
-22.24%
Country
FR
Trade Aelis Farma S.A. (AELIS)

Category

Healthcare
P/E ratio for Aelis Farma S.A. (AELIS)
P/E ratio as of 2026 TTM: 0
According to Aelis Farma S.A. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Aelis Farma S.A. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 29.20 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 30.62 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 32.46 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.